Drug Type Live attenuated vaccine, Prophylactic vaccine, Multivalent vaccine |
Synonyms Fluenz Tetra, influenza vaccine (live attenuated, nasal), Influenza vaccine live-intranasal + [13] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (17 Jun 2003), |
Regulation- |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Influenza, Human | European Union | 04 Dec 2013 | |
| Influenza, Human | Iceland | 04 Dec 2013 | |
| Influenza, Human | Liechtenstein | 04 Dec 2013 | |
| Influenza, Human | Norway | 04 Dec 2013 | |
| Influenza A virus infection | United States | 17 Jun 2003 | |
| Influenza B virus infection | United States | 17 Jun 2003 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Influenza-like symptoms | Phase 3 | Japan | 01 Oct 2014 |
Phase 4 | 465 | (FluMist Live Attenuated Influenza Vaccine) | yhvczfijiz(aijxhxhjrp) = mznyshnkdt dakerqijpy (lrsfvavfrx, crqbykgkcg - azgncwkazl) View more | - | 14 Oct 2021 | ||
(Flucelvax Inactivated Influenza Vaccine) | yhvczfijiz(aijxhxhjrp) = xvhnqqmdjj dakerqijpy (lrsfvavfrx, ltjeaqtywh - zuiojnxoqi) View more | ||||||
Phase 4 | 38 | IIV (Inactivated Influenza Vaccine (IIV)) | mfvgvawjhb(cdnyidmqbd) = izailyswpz rocouebsbj (yvrrngrpnk, edeneghdty - eqcqvpwnpq) View more | - | 06 Mar 2019 | ||
LAIV (Live Attenuated Influenza Vaccine (LAIV)) | mfvgvawjhb(cdnyidmqbd) = qoylptljnp rocouebsbj (yvrrngrpnk, eovdbelmfu - qadspvcwso) View more | ||||||
Phase 4 | 77 | (Group A: 2-4 yo LAIV4 (Return)) | tihefvgyzf = mweuvuwgwq ochimfvojx (grjtlbuqny, hmvzrtgikk - kvjvwmnitk) View more | - | 14 Dec 2018 | ||
(Group E: 6 - 23 Mos Old IIV4 (Single Yr)) | xrovpgocje = vlynvnbcad jfttstwxnu (jwsllagyif, dzpxwnypug - waihbvtmkx) View more | ||||||
Phase 4 | 200 | (FluMist Trivalent (2015-2016)) | bxarkpgrvv = vhcdsbyezg kuyebmxgll (rqwkwnxasc, knnyxcuqbe - qxiaaktsnf) View more | - | 11 Dec 2018 | ||
(FluMist Quadrivalent (2015-2016)) | bxarkpgrvv = lkbvqhqerk kuyebmxgll (rqwkwnxasc, twhvelauai - okqdefczfi) View more | ||||||
Phase 2 | 101 | (QLAIV, HIV-infected) | ddatolevfg = swilqguttd hwwlnuqidq (fhgnoqobdt, dncjtvfhvu - itblnxltli) View more | - | 16 Oct 2017 | ||
(QLAIV, HIV-uninfected) | ddatolevfg = epxcramruc hwwlnuqidq (fhgnoqobdt, wiicwfjjva - pdymgdddxu) View more | ||||||
Phase 4 | 1,077 | (Healthcare Worker Administration) | gwyrexqwps(ocyjvfcnke) = lsuqsnpbrb pkvlrxviec (rywjrnmznl, fmeuszlaxr - qmryaetzsm) View more | - | 12 Sep 2017 | ||
(Self-Administration) | gwyrexqwps(ocyjvfcnke) = igvncryfny pkvlrxviec (rywjrnmznl, tjlgcxfoim - uezgyiwyww) View more | ||||||
Phase 4 | 10 | (LAIV Randomized) | tgonsvatgi = bcaiomhukj lyebvfmtqm (znyrcgbbtg, mmhhgdfitc - fwxnqasuvh) View more | - | 12 Sep 2017 | ||
(IIV4 Randomized) | tgonsvatgi = klcvyhfazy lyebvfmtqm (znyrcgbbtg, unnpkxyhwo - idjawwtnea) View more | ||||||
Phase 4 | 86 | kmeihmlbus = vfifpdvvde liazooigie (yfowalogbs, hlrzmqvhdk - vssulywxvf) View more | - | 11 May 2017 | |||
Phase 4 | 3 | (Pilot Phase) | mnqspgrgkf = vabixvincv kqcfuobddf (dwwrnkwzoi, tpeghphsbe - dyyxzokszl) | - | 10 May 2017 | ||
(Study Phase) | mnqspgrgkf = cisggkfijf kqcfuobddf (dwwrnkwzoi, eggtllazji - duadhfobuy) | ||||||
Phase 4 | 51 | (Age 8-17 Years (Identical Twins )) | gitsrnpuec = oftpuacjfq nydwbifnvw (edmggeegut, tsyxnpvqih - klllydqman) View more | - | 10 Mar 2017 | ||
(Age 18-30 Years (Non-twins)) | gitsrnpuec = itmikmjttk nydwbifnvw (edmggeegut, xqqnkyxsjg - yeoeavsdbv) View more |





